Active, Not Recruiting Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma NCT03224767 Conditions BRAF V600E Mutation Present, Craniopharyngioma, Neoplasms, +5 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States Sutter Cancer Centers Radiation Oncology Services-Auburn — Auburn, California, United States Alta Bates Summit Medical Center-Herrick Campus — Berkeley, California, United States Mills-Peninsula Medical Center — Burlingame, California, United States View all 106 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer NCT04061980 Conditions BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Endocrine Gland Neoplasms, +11 more Locations Providence Portland Medical Center — Portland, Oregon, United States View Trial Details
